GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Althea Group Holdings Ltd (OTCPK:AHGHF) » Definitions » Debt-to-Revenue

Althea Group Holdings (Althea Group Holdings) Debt-to-Revenue : 0.19 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Althea Group Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Althea Group Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.21 Mil. Althea Group Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $3.65 Mil. Althea Group Holdings's annualized Revenue for the quarter that ended in Dec. 2023 was $20.16 Mil. Althea Group Holdings's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.19.


Althea Group Holdings Debt-to-Revenue Historical Data

The historical data trend for Althea Group Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Althea Group Holdings Debt-to-Revenue Chart

Althea Group Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Debt-to-Revenue
- 0.55 0.37 0.26 0.20

Althea Group Holdings Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.25 0.24 0.22 0.18 0.19

Competitive Comparison of Althea Group Holdings's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Althea Group Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Althea Group Holdings's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Althea Group Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Althea Group Holdings's Debt-to-Revenue falls into.



Althea Group Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Althea Group Holdings's Debt-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2.728 + 0.528) / 16.66
=0.20

Althea Group Holdings's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.211 + 3.653) / 20.16
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.


Althea Group Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Althea Group Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Althea Group Holdings (Althea Group Holdings) Business Description

Traded in Other Exchanges
Address
360 Elizabeth Street, Suite 2, Level 50, Melbourne, VIC, AUS, 3000
Althea Group Holdings Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. It operates in three reportable segments Pharmaceutical Cannabis, Recreational Cannabis, and Corporate in which it generates the majority of its revenue from Pharmaceutical Cannabis. It operates into four geographic segments: Australia, the United Kingdom, Canada, and others. The company earns key revenue from Australia and through the sale of medicinal cannabis products.

Althea Group Holdings (Althea Group Holdings) Headlines